Saving Sight: Vision Protection & Blindness Prevention in Diabetes
Over 40% of Americans with diabetes have diabetic retinopathy, but only ~50% are aware that they have it.
Now, we can do something to help. Saving Sight is a quality improvement initiative that provides us with the tools to detect diabetic eye disease in patients who may not otherwise be screened
Diabetic retinopathy is the leading cause of blindness in working-age adults, but timely treatment can reduce the risk of vision loss by 95%.
The following activity is part of the Saving Sight: Vision Protection & Blindness Prevention in Diabetes quality improvement initiative with Boston University Medical Center.
Join distinguished faculty Dr. Jason Worchester and Dr. Tony Pira of Boston University as they examine the tools needed to detect diabetic eye disease and discuss how timely treatment can reduce the risk of vision loss by 95% in diabetic patients.
Geriatricians, family medicine practitioners, internal medicine practitioners, primary care providers, nurses, nurse practitioners, physician assistants.
At the conclusion of this activity, participants will be able to:
- Explain the pathophysiology of diabetic retinopathy and the importance of early screening and treatment as needed
- Describe treatment strategies for diabetic retinopathy
- Describe importance of early referral and treatment for age-related macular degeneration (AMD) and retinal vein occlusion (RVO)
This activity is funded by an independent medical education grant from Regeneron Pharmaceuticals.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and DKBmed. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by DKBmed.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours: 1
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC